New backward-compatible, drug-controllable misexpression tools to investigate intestinal stem cell activation in vivo

This project aims at developing a new method for genetic manipulation in Drosophila, and applying it to understand the baseline activity of the Drosophila adult intestinal stem cells (ISCs) – a sophisticated model for the regulation of intestinal homeostasis.

The activity of ISCs of the Drosophila adult is monitored in vivo through lineage tracing by genetic labelling – the gold standard to analyse tissue stem cell activity. Methods for genetic labelling in Drosophila require the controlled expression of the recombinase FLP, which is generally attained by either a heat shock or a wide temperature switch. These methods preclude analysis of the effect of heat stress on stem cell activity and slow down the pace of research, as rearing flies at low temperature extend the life cycle 3-fold. The latter affects not only stem cell biology but also other fields such as aging or adult metabolism and immunity.

You will implement two independent, complementary approaches aimed at turning the Gal4/UAS misexpression system into a drug-inducible system. This will require engineering repression-release control mechanisms based on the Gal80 protein, the natural repressor of the Gal4 transcriptional activator. Such control mechanism will turn the >20,000 Gal4 transgenes available in Drosophila into drug-inducible with just a simple cross, and is likely to impact the broader Drosophila community. This part of the project will involve molecular cloning and generation of transgenic strains, as well as Drosophila husbandry and expression analysis methods (qRT-PCR, western blot, immunohistochemistry, microscopy).

For more information on this project, please see the following link: https://www.cardiff.ac.uk/study/postgraduate/research/programmes/project/new-backward-compatible,-drug-controllable-misexpression-tools-to-investigate-intestinal-stem-cell-activation-in-vivo